Estrogens modulate the inhibitory effect of tumor necrosis factor-α on anterior pituitary cell proliferation and prolactin release

被引:0
作者
Susana Theas
Daniel Pisera
Beatriz Duvilanski
Andrea De Laurentiis
Macarena Pampillo
Mercedes Lasaga
Adriana Seilicovich
机构
[1] Universidad de Buenos Aires,Centro de Investigaciones en Reproducción, Facultad de Medicina
来源
Endocrine | 2000年 / 12卷
关键词
Tumor necrosis factor-α; anterior pituitary; prolactin; growth; estrogens; estrous cycle;
D O I
暂无
中图分类号
学科分类号
摘要
Considering that tumor necrosis factor-α (TNF-α) is involved in normal tissue homeostasis and that its receptors are expressed in the anterior pituitary, we examined the expressed in the anterior pituitary, we examined the effect of this cytokine on pituitary cell growth. Because anterior pituitary function depends on hormonal environment, we also investigated the influence of gonadal steroids in the effects of TNF-α on cell proliferation and the release of PRL from anterior pituitary cells. In addition, the release of TNF-α and its action on the release of PRL from anterior pituitary cells of rats at different stages of the estrous cycle was evaluated. In minimum essential medium D-valine, a medium that restricts fibroblastic proliferation, TNF-α (10 and 50 ng/mL) reduced 3H-Thymidine incorporation, DNA content, and active cell number. TNF-α failed to affect proliferation of cells from ovariectomized (OVX) rats. However, it significantly inhibited growth of cells from OVX rats cultured with 17ß-estradiol (E2) (10−9M) and from chronically estrogenized rats. TNF-α decreased the release of PRL from cells of intact rats, especially in proestrous, OVX rats cultured with E2 and chronically estrogenized rats. The release of anterior pituitary TNF-α was higher in proestrous rats. These results indicate that TNF-α plays and inhibitory role in anterior pituitary cell growth and the release of PRL in an estrogen-dependent manner.
引用
收藏
页码:249 / 255
页数:6
相关论文
共 168 条
[1]  
Lamberts S. W. J.(1990)undefined Physiol. Rev. 70 279-318
[2]  
MacLeod R. M.(1997)undefined Endocr. Rev. 18 206-228
[3]  
Ray D.(1999)undefined Front. Neuroendocrinol. 20 71-95
[4]  
Melmed S.(1990)undefined Br. J. Cancer 61 354-361
[5]  
Arzt E.(1995)undefined Neuroendocrinology 62 55-61
[6]  
Páez Pereda M.(1998)undefined Endocrine 8 241-245
[7]  
Perez Castro C.(1999)undefined J. Neuropathol. Exp. Neurol. 58 61-77
[8]  
Pagotto U.(1999)undefined J. Neuropathol. Exp. Neurol. 58 61-77
[9]  
Renner U.(1989)undefined Proc. Natl. Acad. Sci. USA 86 2418-2422
[10]  
Stalla G. K.(1991)undefined Endocrinology 128 2785-2790